The last few years have witnessed a tremendous growth of the demand for wireless services and a significant increase of the number of mobile subscribers. A recent data traffic forecast from Cisco reported that the global mobile data traffic reached 1.2 zettabytes per year in 2016, and the global IP traffic will increase nearly threefold over the next 5 years. Based on these predictions, a 127-fold increase of the IP traffic is expected from 2005 to 2021. It is also anticipated that the mobile data traffic will reach 3.3 zettabytes per year by 2021, and that the number of mobile-connected devices will reach 3.5 per capita.
With such demands for higher data rates and for better quality of service (QoS), fifth generation (5G) standardization initiatives, whose initial phase was specified in June 2018 under the umbrella of Long Term Evolution (LTE) Release 15, have been under vibrant investigation. In particular, the International Telecommunication Union (ITU) has identified three usage scenarios (service categories) for 5G wireless networks: (i) enhanced mobile broadband (eMBB), (ii) ultra-reliable and low latency communications (uRLLC), and (iii) massive machine type communications (mMTC). The vast variety of applications for beyond 5G wireless networks has motivated the necessity of novel and more flexible physical layer (PHY) technologies, which are capable of providing higher spectral and energy efficiencies, as well as reduced transceiver implementations.
1. IEEE Signal Processing Magazine
2. Signal Processing Digital Library*
3. Inside Signal Processing Newsletter
4. SPS Resource Center
5. Career advancement & recognition
6. Discounts on conferences and publications
7. Professional networking
8. Communities for students, young professionals, and women
9. Volunteer opportunities
10. Coming soon! PDH/CEU credits
Click here to learn more.
10 years of news and resources for members of the IEEE Signal Processing Society
The emergence of high throughput technologies is enabling the characterization of cancer genomes at unprecedented resolution and scale. However, such data suffer from the typical limitations of observational studies, which are frequently challenged by their inability to differentiate between causality and correlation. Recently, several datasets of genome-wide functional assays performed on tumor cell lines have become available. Given the ability of these assays to interrogate cancer genomes for the function of each individual gene, these data can provide vital cues to identify causal events and, with them, novel drug targets. Unfortunately, current analytical methods have been unable to overcome the challenges posed by these assays, which include poor signal to noise ratio and wide-spread off-target effects.
Given the largely orthogonal strengths and weaknesses of descriptive analysis of genetic and genomic observational data from cancer genomes and genome-wide functional screening, I hypothesized that integrating the two data types into unified computational models would significantly increase the power of the biological analysis. In this dissertation I use integrative approaches to tackle two crucial problems in cancer research: the identification of driver genes and the discovery of tumor lethalities. I use the resulting methods to study breast cancer, the second most common form of this disease.
The first part of the dissertation focuses on the analysis of regions of copy number alteration for the identification of driver genes. I first describe how a simple integrative method enabled the identification of BIN3, a novel driver of metastasis in breast cancer. I then describe Helios, an unsupervised method for the identification of driver genes in regions of SCNA that integrates different data sources into a single probabilistic score. Applying Helios to breast cancer data identified a set of candidate drivers highly enriched with known drivers (p-value < e-14). In vitro validation of 12 novel candidates predicted by Helios found 10 conferred enhanced anchorage independent growth, demonstrating Helios's exquisite sensitivity and specificity. I further provide an extensive characterization of RSF-1, a driver identified by Helios whose amplification correlates with poor prognosis, which displayed increased tumorigenesis and metastasis in mouse models.
The second part of this dissertation addresses the problem of identifying tumor vulnerabilities using genome-wide shRNA screens across tumor cell lines. I approach this endeavor using a novel integrative method that employs different biomarkers of cellular state to facilitate the identification of clusters of hairpins with similar phenotype. When applied to breast cancer data, the method not only recapitulates the main subtypes and lethalities associated to this malignancy, but also identifies several novel putative lethalities.
Taken together, this research demonstrates the importance of the computational integration of genome-wide functional and observational data in cancer research, providing novel approaches that yield important insights into the biology of the disease.
For details, please visit the thesis page.
© Copyright 2019 IEEE – All rights reserved. Use of this website signifies your agreement to the IEEE Terms and Conditions.
A not-for-profit organization, IEEE is the world's largest technical professional organization dedicated to advancing technology for the benefit of humanity.